Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Strategic Projects - Group

University of Manitoba

$109,000.00

Enhanced microwave tomography for biomedical imaging

EF 2011-12

Résumé
The main research goal is to enhance the spatial resolution of state-of-the-art Microwave Tomography (MWT) systems for biomedical imaging. MWT is a relatively new modality that uses microwave measurements to create a quantitative image of the bulk-electrical material properties of biological tissues situated in a body. Although some recent results for breast cancer imaging are impressive, MWT has not become the modality of choice for any biomedical application. This is mostly due to the limited spatial resolution of the current state-of-the-art. But there are many potential advantages of MWT, including (1) its low cost and portability; (2) its use of safe non-ionizing radiation; and (3) its ability, without contrast agents, to create quantitative images of the dielectric constant and conductivity of living tissue as a way of identifying physiological conditions of those tissues. This would allow the early detection of disease via strategic frequent monitoring of patients. The research addresses MWT's greatest challenge: its lower spatial resolution as compared to other existing modalities. The research investigates enhancing the spatial resolution by building a series of 3D imaging prototypes capable of measuring vector-fields in the near-field. The two main novel areas around which this research revolves are (a) the accurate measurement of vector-fields over 3D surfaces in the near-field region, and (b) the use of conductive enclosures within which the measurements are made. Prototype MWT systems incorporating these novel features will be built using advanced antenna-array techniques, accurate numerical calibration, and state-of-the-art inversion algorithms. We will investigate the feasibility of MWT for specialized biomedical applications and transferring the technology to our supporting organizations, CancerCare Manitoba (CCMB) & IMRIS. All testing and evaluation of the enhanced spatial resolution will be accomplished on specially designed phantoms. Access to such prototype systems will provide CCMB & IMRIS with valuable information on the viability of MWT for future clinical applications. Current indications are that MWT can be useful for breast cancer imaging, bone imaging, and the detection of ischemic tissues
Programme
Strategic Projects - Group
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
396645-2010
Name nom
LoVetri, Joe
Department département
Electrical and Computer Engineering
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
109000
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1042
Committee name en
Strategic Projects Selection Panel - Biomedical Technologies
Committee name fr
Comité de sélection des projets stratégiques - Technologies biomédicales
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
2
Nb partie
3
Application title
Enhanced microwave tomography for biomedical imaging
Keyword
NSERC
Application summary
The main research goal is to enhance the spatial resolution of state-of-the-art Microwave Tomography (MWT) systems for biomedical imaging. MWT is a relatively new modality that uses microwave measurements to create a quantitative image of the bulk-electrical material properties of biological tissues situated in a body. Although some recent results for breast cancer imaging are impressive, MWT has not become the modality of choice for any biomedical application. This is mostly due to the limited spatial resolution of the current state-of-the-art. But there are many potential advantages of MWT, including (1) its low cost and portability; (2) its use of safe non-ionizing radiation; and (3) its ability, without contrast agents, to create quantitative images of the dielectric constant and conductivity of living tissue as a way of identifying physiological conditions of those tissues. This would allow the early detection of disease via strategic frequent monitoring of patients. The research addresses MWT's greatest challenge: its lower spatial resolution as compared to other existing modalities. The research investigates enhancing the spatial resolution by building a series of 3D imaging prototypes capable of measuring vector-fields in the near-field. The two main novel areas around which this research revolves are (a) the accurate measurement of vector-fields over 3D surfaces in the near-field region, and (b) the use of conductive enclosures within which the measurements are made. Prototype MWT systems incorporating these novel features will be built using advanced antenna-array techniques, accurate numerical calibration, and state-of-the-art inversion algorithms. We will investigate the feasibility of MWT for specialized biomedical applications and transferring the technology to our supporting organizations, CancerCare Manitoba (CCMB) & IMRIS. All testing and evaluation of the enhanced spatial resolution will be accomplished on specially designed phantoms. Access to such prototype systems will provide CCMB & IMRIS with valuable information on the viability of MWT for future clinical applications. Current indications are that MWT can be useful for breast cancer imaging, bone imaging, and the detection of ischemic tissues